Showing results 1 to 20 of 80
next >
| Issue Date | Title | Author(s) |
| 2015 | Acquired Resistance Mechanisms in Small Cell Lung Cancer Mediated by the Cancer Stem Cell Marker Calcium Channel alpha 2 delta 1 Subunit | Wang, Jie; Yu, Jiangyong; Tian, Yanhua; Bai, Hua; Wang, Zhijie; Yu, Sifan |
| 2015 | Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations | Wang, Zhijie; Shen, Zhirong; Li, Zhenxiang; Duan, Jianchun; Fu, Shuai; Liu, Zhentao; Bai, Hua; Zhang, Zemin; Zhao, Jun; Wang, Xiaodong; Wang, Jie |
| 2015 | Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinomas patients with EGFR mutations. | Wang, Jie; Wang, Zhijie; Li, Zhenxiang; Shen, Zhirong; Fu, Shuai; Liu, Zhentao; Cheng, Liang; Bai, Hua; Duan, Jianchun; Zhao, Jun; Wang, Shuhang; Zhuo, Minglei |
| 2015 | Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinomas patients with EGFR mutations. | Wang, Jie; Wang, Zhijie; Li, Zhenxiang; Shen, Zhirong; Fu, Shuai; Liu, Zhentao; Cheng, Liang; Bai, Hua; Duan, Jianchun; Zhao, Jun; Wang, Shuhang; Zhuo, Minglei |
| Apr-2020 | Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors | Wang, Zhijie; Duan, Jianchun; Wang, Guoqiang; Zhao, Jing; Xu, Jiachen; Han, Jiefei; Zhao, Zhengyi; Zhao, Jun; Zhu, Bo; Zhuo, Minglei; Sun, Jianguo; Bai, Hua; Wan, Rui; Wang, Xin; Fei, Kailun; Wang, Shuhang; Zhao, Xiaochen; Zhang, Yuzi; Huang, Mengli; Huang, Depei; Qi, Chuang; Gao, Chan; Bai, Yuezong; Dong, Hua; Xiong, Lei; Tian, Yanhua; Wang, Di; Xu, Chunwei; Wang, Wenxian; Li, Junling; Hu, Xingsheng; Cai, Shangli; Wang, Jie |
| 2013 | ANALYSIS OF SENSITIVITY OF LUNG SQUAMOUS CARCINOMA WITH EGFR MUTATION TO EGFR-TKIS AND RESISTANT MECHANISM | Wang, Zhijie; Li, Zhenxiang; Yang, Xiaodan; Bai, Hua; Zhuo, Minglei; Duan, Jianchun; Wang, Jie |
| 5-Jan-2024 | Analysis of the Genetic Characteristics and Metastatic Pathways of G1 and G2 Colorectal Neuroendocrine Neoplasms | Wang, Zhijie; Chen, Qichen; Zhao, Fuqiang; Sun, Li; Qiu, Yixian; Cheng, Huanqing; Qin, Jiayue; Wang, Huina; Shi, Susheng; Cao, Shanbo; Liu, Qian |
| 5-Jan-2024 | Analysis of the Genetic Characteristics and Metastatic Pathways of G1 and G2 Colorectal Neuroendocrine Neoplasms | Wang, Zhijie; Chen, Qichen; Zhao, Fuqiang; Sun, Li; Qiu, Yixian; Cheng, Huanqing; Qin, Jiayue; Wang, Huina; Shi, Susheng; Cao, Shanbo; Liu, Qian |
| 2018 | Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer | Lv, Chunxin; Liu, Xiuju; Zheng, Qiwen; Chen, Hanxiao; Yang, Xue; Zhong, Jia; Wang, Yuyan; Duan, Jianchun; Wang, Zhijie; Bai, Hua; Wu, Meina; Zhao, Jun; Wang, Jie; Wang, Ziping; An, Tongtong; Zhuo, Minglei |
| 2009 | The application of SnS nanoparticles to bulk heterojunction solar cells | Wang, Zhijie; Qu, Shengchun; Zeng, Xiangbo; Liu, Junpeng; Zhang, Changsha; Tan, Furui; Jin, Lan; Wang, Zhanguo |
| 2019 | Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel | Wang, Zhijie; Duan, Jianchun; Cai, Shangli; Han, Miao; Dong, Hua; Zhao, Jun; Zhu, Bo; Wang, Shuhang; Zhuo, Minglei; Sun, Jianguo; Wang, Qiming; Bai, Hua; Han, Jiefei; Tian, Yanhua; Lu, Jing; Xu, Tongfu; Zhao, Xiaochen; Wang, Guoqiang; Cao, Xinkai; Li, Fugen; Wang, Dalei; Chen, Yuejun; Bai, Yuezong; Zhao, Jing; Zhao, Zhengyi; Zhang, Yuzi; Xiong, Lei; He, Jie; Gao, Shugeng; Wang, Jie |
| 1-Jun-2022 | Blockade of STAT3/IL-4 overcomes EGFR T790M-cis-L792F-induced resistance to osimertinib via promoting M2 macrophages polarization. | Sun, Yiting; Ma, Yuanyuan; Tian, Zhihua; Liu, Xijuan; Yan, Xiang; Zhao, Wei; Wang, Jie; Wang, Zhijie |
| Feb-2021 | Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial | Fan, Yun; Zhao, Jun; Wang, Qiming; Huang, Dingzhi; Li, Xingya; Chen, Jianhua; Fang, Yong; Duan, Jianchun; Zhou, Caicun; Hu, Yanping; Yang, Haihua; Hu, Yi; Zhou, Jianying; Lin, Xiaoyan; Wang, Lifeng; Wang, Zhijie; Xu, Yanjun; Zhang, Tao; Shi, Wei; Zou, Jianjun; Wang, Jie |
| Aug-2020 | Camrelizumab plus apatinib in extensive-stage small-cell lung cancer (PASSION): A multicenter, two-stage, phase 2 trial | Wang, Jie; Fan, Yun; Zhao, Jun; Wang, Qiming; Huang, Dingzhi; Li, Xingya; Chen, Jianhua; Fang, Yong; Wang, Zhijie; Zhou, Caicun; Hu, Yanping; Yang, Haihua; Hu, Yi; Zhou, Jianying; Lin, Xiaoyan; Wang, Lifeng; Xu, Yanjun; Li, Hanying |
| 2023 | Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer | Huang, Dingzhi; Lin, Gen; Chu, Qian; Hu, Yi; Wang, Jun; Wang, Zhijie; Yang, Fan; Zhong, Wenzhao; Zhou, Chengzhi; Zhu, Bo; Ai, Xinghao; Cao, Baoshan; Cao, Yabing; Chen, Mingqiu; Chen, Xiaohui; Chu, Tianqing; Duan, Jianchun; Fan, Yun; Fang, Yong; Feng, Shuitu; Feng, Weineng; Guo, Hui; Han, Chengbo; He, Yong; Hong, Shaodong; Hu, Jie; Huang, Meijuan; Huang, Yan; Jiang, Da; Jiang, Kan; Jiang, Richeng; Jin, Bo; Jin, Shi; Li, Jisheng; Li, Min; Li, Ziming; Li, Chao; Lin, Jie; Liu, Anwen; Liu, Si-Yang Maggie; Liu, Yutao; Liu, Zhefeng; Liu, Zhe; Liu, Zhenhua; Liu, Zhentian; Liu, Zhigang; Lu, Yuping; Lv, Tangfeng; Ma, Zhiyong; Miao, Qian; Peng, Min; Pu, Xingxiang; Ren, Xiu Bao; Shan, Jianzhen; Shan, Jinlu; Shen, Peng; Shen, Bo; Shi, Meiqi; Song, Yong; Song, Zhengbo; Su, ChunXia; Sun, Jianguo; Tian, Panwen; Wang, Jinliang; Wang, Feng; Wang, Huijuan; Wang, Jialei; Wang, Qian; Wang, Wenxian; Wang, Yan; Wu, Lin; Wu, Fang; Xia, Yang; Xie, Congying; Xie, Conghua; Xin, Tao; Xiong, Jianping; Xu, Haipeng; Xu, Song; Xu, Yiquan; Xu, Bin; Xu, Chunwei; Yan, Xiaolong; Yang, Zhenzhou; Yao, Wenxiu; Yu, Yao; Feng, Ye; Yu, Zongyang; Yu, Yongfeng; Yue, Dongsheng; Zhang, Haibo; Zhang, HongMei; Zhang, Li; Zhang, Longfeng; Zhang, Qiuyu; Zhang, Tongmei; Zhang, Bicheng; Zhao, Jun; Zhao, Mingfang; Zheng, Xiaobin; Zhong, Fengqiao; Zhou, Jin; Zhou, Penghui; Zhu, Zhengfei; Zou, Juntao; Zou, Zihua |
| 2013 | Clinical features of patients with lung adenocarcinomas harboring BRAF V600E mutations | An, Tongtong; Wang, Jie; Bai, Hua; Wang, Zhijie; Zhao, Jun; Duan, Jianchun; Zhuo, Minglei; Wu, Meina; Wang, Yuyan; Wang, Shuhang |
| 2017 | Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer | Wan, Rui; Wang, Zhijie; Lee, J. Jack; Wang, Shuhang; Li, Qingqing; Tang, Fuchou; Wang, Jin; Sun, Yu; Bai, Hua; Wang, Di; Zhao, Jun; Duan, Jianchun; Zhuo, Minglei; An, Tongtong; Wu, Meina; Chen, Zhaoli; Yang, Zhenlin; Wang, Jie |
| 2016 | Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience | Hou, Ming-Mo; Wang, Zhijie; Janku, Filip; Piha-Paul, Sarina; Naing, Aung; Hong, David; Westin, Shannon; Coleman, Robert L.; Sood, Anil K.; Tsimberidou, Apostolia M.; Subbiah, Vivek; Wheler, Jennifer; Zinner, Ralph; Lu, Karen; Meric-Bernstam, Funda; Fu, Siqing |
| 2013 | Cytoplasmic ER beta expression to predict efficacy and survival of EGFR-TKI in EGFR-mutant NSCLC | Wang, Zhijie; Wang, Jie; Wang, Xiaodong; Shen, Zhirong; Ding, Xiaosheng; Bai, Hua; Duan, Jianchun; An, Tongtong; Wang, Yuyan; Zhuo, Minglei; Wang, Shuhang; Wu, Meina |
| 2013 | CYTOPLASMIC ERBEXPRESSION PREDICTS POORLY EFFICACY AND SURVIVAL OF EGFR-TKI IN EGFR MUTANT NSCLC | Wang, Zhijie; Li, Zhenxiang; Bai, Hua; Wang, Jie; Zhao, Jun; Wu, Meina |
